Group One Trading’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,300
Closed -$2.04M 8427
2022
Q3
$2.04M Buy
8,300
+4,900
+144% +$1.32M ﹤0.01% 1903
2022
Q2
$842K Sell
3,400
-7,300
-68% -$1.97M ﹤0.01% 2927
2022
Q1
$3.54M Buy
10,700
+10,600
+10,600% +$3.26M ﹤0.01% 1828
2021
Q4
$36K Sell
100
-300
-75% -$101K ﹤0.01% 6573
2021
Q3
$130K Buy
400
+300
+300% +$102K ﹤0.01% 5638
2021
Q2
$31K Sell
100
-6,700
-99% -$2.06M ﹤0.01% 6952
2021
Q1
$2.17M Sell
6,800
-12,700
-65% -$4.06M ﹤0.01% 2381
2020
Q4
$6.32M Buy
19,500
+1,100
+6% +$304K 0.01% 1121
2020
Q3
$5.1M Sell
18,400
-5,000
-21% -$1.44M 0.02% 906
2020
Q2
$5.65M Buy
23,400
+17,400
+290% +$3.49M 0.03% 729
2020
Q1
$871K Sell
6,000
-9,000
-60% -$1.49M 0.01% 1627
2019
Q4
$2.56M Sell
15,000
-300
-2% -$55.6K 0.02% 1104
2019
Q3
$2.72M Sell
15,300
-1,500
-9% -$324K 0.02% 975
2019
Q2
$4.38M Sell
16,800
-43,100
-72% -$11.4M 0.04% 598
2019
Q1
$17.1M Buy
59,900
+32,200
+116% +$10.7M 0.19% 91
2018
Q4
$9M Buy
27,700
+7,300
+36% +$2.54M 0.08% 284
2018
Q3
$9.18M Buy
20,400
+7,700
+61% +$3.04M 0.07% 312
2018
Q2
$5.2M Buy
12,700
+4,100
+48% +$1.49M 0.04% 527
2018
Q1
$2.5M Buy
8,600
+3,400
+65% +$862K 0.03% 853
2017
Q4
$975K Buy
5,200
+4,600
+767% +$859K 0.01% 1718
2017
Q3
$101K Buy
600
+400
+200% +$60.5K ﹤0.01% 3240
2017
Q2
$29K Hold
200
﹤0.01% 3801
2017
Q1
$25K Sell
200
-1,800
-90% -$209K ﹤0.01% 3789
2016
Q4
$225K Buy
+2,000
New +$232K ﹤0.01% 2344
2013
Q3
Sell
-14,500
Closed -$313K 5705
2013
Q2
$313K Buy
+14,500
New +$291K 0.01% 1756

Other funds holding ABMD

Group One Trading's ABMD Position: Q1 2022 in Review

Group One Trading sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 1,509 shares — an estimated $465K sold.

Group One Trading first reported a position in ABMD in Q3 2014 and held it in 25 quarters. The position peaked at $3.77M in Q2 2019. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Group One Trading reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 1,509 Abiomed Inc shares in Q1 2022, an estimated $465K.
  • Group One Trading first reported a position in Abiomed Inc in Q3 2014 and held it in 25 quarters.
  • Group One Trading's Abiomed Inc position peaked at $3.77M in Q2 2019.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.